We are live on ! Find out more
MLICM

Metropolitan Life Insurance Company (MetLife) Portfolio holdings

AUM $357M
1-Year Est. Return 13.97%
This Fund
S&P 500
This Quarter Est. Return
+9.51%
1 Year Est. Return
+13.97%
3 Year Est. Return
+50.79%
5 Year Est. Return
+74.78%
10 Year Est. Return
+368.42%
AUM
$2.24B
AUM Growth
+$127M
Cap. Flow
-$22.4M
Cap. Flow %
-1%
Top 10 Hldgs %
23.56%
Holding
2,404
New
91
Increased
577
Reduced
648
Closed
51

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$5.38M
2
EFA icon
iShares MSCI EAFE ETF
EFA
+$3.16M
3
XOM icon
ExxonMobil
XOM
+$2.1M
4
MSFT icon
Microsoft
MSFT
+$1.73M
5
TWTR
Twitter, Inc.
TWTR
+$1.72M

Sector Composition

Rank Sector Weight
1 Technology 20.14%
2 Healthcare 13.99%
3 Financials 12.61%
4 Consumer Discretionary 8.54%
5 Industrials 8.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MRTN icon
1226
Marten Transport
MRTN
$1.22B
$74.4K ﹤0.01%
3,763
PRIM icon
1227
Primoris Services
PRIM
$4.35B
$74.4K ﹤0.01%
3,389
KALU icon
1228
Kaiser Aluminum
KALU
$2.99B
$74.3K ﹤0.01%
978
+74
+8% +$5.92K
MHO icon
1229
M/I Homes
MHO
$3.82B
$74.3K ﹤0.01%
1,608
UMH
1230
UMH Properties
UMH
$1.39B
$74.2K ﹤0.01%
4,609
+22
+0.5% +$370
ENVA icon
1231
Enova International
ENVA
$6.52B
$74.1K ﹤0.01%
1,931
PAYO icon
1232
Payoneer
PAYO
$2.42B
$74K ﹤0.01%
13,535
TTGT icon
1233
TechTarget
TTGT
$265M
$73.7K ﹤0.01%
1,673
+59
+4% +$3.09K
ECPG icon
1234
Encore Capital Group
ECPG
$2.07B
$73.7K ﹤0.01%
1,537
BATRK icon
1235
Atlanta Braves Holdings Series B
BATRK
$3.41B
$73.7K ﹤0.01%
2,286
-219
-9% -$6.83K
RNAM
1236
DELISTED
Avidity Biosciences
RNAM
$73.5K ﹤0.01%
3,311
+339
+11% +$5.05K
NBHC icon
1237
National Bank Holdings
NBHC
$1.94B
$73.3K ﹤0.01%
1,743
PMT
1238
PennyMac Mortgage Investment
PMT
$827M
$73.3K ﹤0.01%
5,917
DHT icon
1239
DHT Holdings
DHT
$3.09B
$73.3K ﹤0.01%
8,252
VICR icon
1240
Vicor
VICR
$10.4B
$73.2K ﹤0.01%
1,361
+74
+6% +$3.89K
EIG icon
1241
Employers Holdings
EIG
$864M
$73.1K ﹤0.01%
1,695
BGC icon
1242
BGC Group
BGC
$5.2B
$72.8K ﹤0.01%
19,314
ALHC icon
1243
Alignment Healthcare
ALHC
$2.79B
$72.7K ﹤0.01%
6,184
+668
+12% +$8.13K
SXI icon
1244
Standex International
SXI
$4B
$72.7K ﹤0.01%
710
UPBD icon
1245
Upbound Group
UPBD
$1.15B
$72.7K ﹤0.01%
3,224
MYGN icon
1246
Myriad Genetics
MYGN
$303M
$72.7K ﹤0.01%
5,010
HNI icon
1247
HNI Corp
HNI
$3.55B
$72.6K ﹤0.01%
2,554
CTKB icon
1248
Cytek Biosciences
CTKB
$636M
$72.3K ﹤0.01%
7,083
SPHR icon
1249
Sphere Entertainment
SPHR
$6.33B
$72.1K ﹤0.01%
1,603
AHRT
1250
AH Realty Trust
AHRT
$501M
$71.9K ﹤0.01%
6,255
+342
+6% +$3.94K

Similar funds

Metropolitan Life Insurance Company (MetLife)'s Q4 2022 Portfolio in Review

As of Q4 2022, Metropolitan Life Insurance Company (MetLife) held 2,404 positions worth $2.24B, up 6% from $2.11B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Metropolitan Life Insurance Company (MetLife)'s Q4 2022 filing shows 91 new, 577 increased, 648 reduced and 51 closed positions. Its largest new stake was Vanguard Total Bond Market: 419,639 shares worth $30.1M. The largest sale was Apple, an estimated $5.38M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 21% a quarter earlier, followed by Healthcare and Financials.

  • Metropolitan Life Insurance Company (MetLife)'s largest Q4 2022 buy was Vanguard Total Bond Market: 419,639 shares worth $30.1M.
  • Metropolitan Life Insurance Company (MetLife) added most to State Street SPDR S&P 500 ETF Trust in Q4 2022, an estimated $22.6M increase.
  • Metropolitan Life Insurance Company (MetLife)'s biggest Q4 2022 reduction was Apple, cutting an estimated $5.38M.
  • Metropolitan Life Insurance Company (MetLife) fully exited Twitter, Inc. in Q4 2022, selling an estimated $1.72M.
  • Metropolitan Life Insurance Company (MetLife)'s ten largest holdings make up 24% of its $2.24B portfolio in Q4 2022.
  • Metropolitan Life Insurance Company (MetLife) opened 91 new positions and closed 51 in Q4 2022.
  • Metropolitan Life Insurance Company (MetLife)'s portfolio value rose 6% quarter-over-quarter to $2.24B.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q4 2022, filed 15 Feb 2023.